(Q47344886)

14 January 2018

title

Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model (English)

1 reference

14 January 2018

Magnesium Sulfate Reduces Myocardial Infarct Size When Administered Before but Not After Coronary Reperfusion in a Canine Model (English)

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

25 May 2024

0 references

0 references

1 reference

C. W. Christensen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586364

25 May 2024

M. A. Rieder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586364

25 May 2024

E. L. Silverstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586364

25 May 2024

N. E. Gencheff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586364

25 May 2024

language of work or name

English

0 references

publication date

1 November 1995

1 reference

14 January 2018

full work available at URL

https://www.ahajournals.org/doi/full/10.1161/01.CIR.92.9.2617

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

25 May 2024

1 reference

14 January 2018

volume

92

1 reference

14 January 2018

issue

9

1 reference

14 January 2018

page(s)

2617-2621

1 reference

14 January 2018

Comparative effects of propranolol, timolol and metoprolol on myocardial infarct size after experimental coronary artery occlusion

cites work

2

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

25 May 2024

6

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

25 May 2024

7

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

Effects of magnesium sulfate on cardiac conduction and refractoriness in humans.

25 May 2024

9

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

Magnesium deficiency and myocardial infarct size in the dog.

25 May 2024

10

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

Influence of low-flow infusion and magnesium on tissue necrosis during regional ischemia in the canine myocardium

25 May 2024

11

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

Total and Regional Coronary Blood Flow Measured by Radioactive Microspheres in Conscious and Anesthetized Dogs

25 May 2024

12

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

Hemodynamic effects of magnesium sulfate on the normal human heart.

25 May 2024

13

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium").

25 May 2024

15

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells

25 May 2024

18

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

Beneficial effect of magnesium sulfate in acute myocardial infarction.

25 May 2024

19

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

Effects of AQ-AH 208, a new specific bradycardic agent, on myocardial ischemia-reperfusion injury in anesthetized dogs.

25 May 2024

20

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.9.2617

25 May 2024

Identifiers

1 reference

14 January 2018

1 reference

14 January 2018